Skip to main content
EnglishEnglish
EnglishEnglishArabicArabicChinese (Simplified)Chinese (Simplified)FrenchFrenchGermanGermanHindiHindiPortuguesePortugueseRussianRussianSpanishSpanishSwahiliSwahili

Header

  • Contact us
Home The Task Force for Global Health logo
  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep
Donate
Add a Program
Add a Program
Profile
Logout

Main navigation

  • About
    • Who we are
    • What we do
    • Our team
    • Technical Advisory Board
    • Executive Board
    • Donor Acknowledgements
  • Programs
    • Programs search
  • Data dashboards
  • Evidence base
    • All evidence (search)
      • Evidence Base Methodology
    • Action plans
    • Hepatitis B Birth Dose Vaccine
      • Synthesis Brief of Hepatitis B Birth Dose Evidence Base
    • HCV Testing
    • COVID-19
      • Clinical Liver Disease COVID-19 special series
        • The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
        • Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic
      • COVID-19 and Liver Disease Synthesis
    • Innovations in Hepatitis Elimination (CLD Series)
      • Author Interviews
      • Introduction to Series
      • Past Publications
      • Author Guidance
  • Resources
    • Hepatitis Elimination Help Desk
    • Search resources
  • Webinars
    • Hep Test
    • Strategic Information Collaborative
    • Innovations in Hepatitis Elimination
  • Elimination champions
    • Elimination Champions
    • Nominations for Elimination Champions
  • News
    • News search
  1. Home
  2. Evidence base
  3. Evidence base search

Evidence base articles search

The evidence base was developed using rigorous review methods for the identification and quality assessment of eligible systematic reviews and guideline and policy documents. In response to identified global research priorities, the evidence base currently presents characteristics of interventions to inform implementation of hepatitis B birth dose and hepatitis B and C action plans. Updates to the evidence base are planned to address subsequent priorities.

Edit

Evidence base search

Filter

  • (-) HCV testing
  • Hepatitis B
  • Hepatitis C
  • Coinfection with HIV
  • HBV testing and linkage to care
  • HCV testing and linkage to Care
  • Linkage to care
  • Persons who inject drugs: Medication assisted therapy
  • Screening and diagnosis
  • Testing
  • Treatment
  • Adolescents (10 - 19 years of age)
  • Adults
  • Adults (> 19 years of age)
  • All ages
  • Birth cohorts of adults
  • Blood transfusion recipients
  • Dialysis patients
  • General Population
  • Immigrants/Refugees
  • Incarcerated populations (current and former)
  • Individuals with blood disorders
  • Men who have sex with men
  • People experiencing homelessness
  • Persons who inject drugs
  • Persons with substance use disorder
  • Pregnant women
  • Young Adults <21
  • Cross-sectional
  • Prospective cohort
  • Randomized control trial
  • Retrospective cohort
  • Australia
  • Belgium
  • Brazil
  • Cambodia
  • Cameroon
  • Canada
  • Chad
  • China
  • Egypt
  • France
  • Georgia
  • Germany
  • Hong Kong
  • India
  • Iran (Islamic Republic of)
  • Ireland
  • Italy
  • Japan
  • Kenya
  • Korea (Republic of)
  • Malaysia
  • Netherlands
  • Norway
  • Pakistan
  • Poland
  • Portugal
  • Russian Federation
  • Serbia
  • Spain
  • Sri Lanka
  • Sweden
  • Switzerland
  • Taiwan
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States of America
  • Viet Nam
  • Laboratory-based antibody test
  • Laboratory-based antibody test,Laboratory-based HCV core antigen (cAg) confirmatory test
  • Laboratory-based antibody test,Laboratory-based PCR/RNA (confirmatory) test
  • Laboratory-based antibody test, Point-of-care PCR/RNA test
  • Laboratory-based HCV core antigen (cAg) confirmatory test
  • Laboratory-based PCR/RNA (confirmatory) test
  • Point-of-care antibody test (rapid test)
  • Point-of-care antibody test (rapid test), Laboratory-based PCR/RNA (confirmatory) test
  • Point-of-care antibody test (rapid test), Point-of-care PCR/RNA test
  • Point-of-care antibody test (rapid test), Laboratory-based HCV core antigen (cAg) confirmatory test
  • Point-of-care PCR/RNA test
Displaying 1 - 12 of 163
  • Change in treatment paradigm in people who previously injected drugs with chronic hepatitis C in the era of direct-acting antiviral therapy

    2019
    Journal of Gastroenterology and Hepatology (Australia)

    34

    1641-1647
  • Hepatitis C Virus Infection in the Dallas County Jail: Implications for Screening, Prevention, and Linkage to Care

    2019
    Public Health Reports

    134

    626-633
  • Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: The HITS-c study

    2014
    Medical Journal of Australia

    201

    326-329
  • Awareness of biologically confirmed HCV among a community residing sample of drug users in Baltimore City

    2014
    Journal of Community Health

    39

  • Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios

    2015
    Journal of Hepatology

    62

    12561264
  • Outbreak of hepatitis C virus infection associated with narcotics diversion by an hepatitis C viruseinfected surgical technician

    2015
    American Journal of Infection Control

    43

    53-58
  • Is there a benefit for health care workers in testing HIV, HCV and HBV in routine before elective arthroplasty?

    2016
    Orthopaedics and Traumatology: Surgery and Research

    102

    513-516
  • Targeted hepatitis C screening among ex-injection drug users in the community

    2014
    Journal of Gastroenterology and Hepatology (Australia)

    29

    116-120
  • Screening a nation for hepatitis C virus elimination: A cross-sectional study on prevalence of hepatitis C and associated risk factors in the Rwandan general population

    2019
    BMJ Open

    9 (7)

  • Health risk and health seeking behaviours among people who inject performance and image enhancing drugs who access needle syringe programs in Australia

    2018
    Drug and alcohol review

    37

    837-846
  • High priority for hepatitis C screening in safety net hospitals: Results from a prospective cohort of 4582 hospitalized baby boomers

    2015
    Hepatology

    62

    1388-1395
  • The use of complementary serological and molecular testing for blood-borne pathogens and evaluation of socio-demographic characteristics of intravenous drug users on substitution therapy from Sumadia district of Serbia

    2019
    Vojnosanitetski Pregled

    76

    587-592

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page ››
  • Last page Last »

Contact us

globalhep [at] taskforce.org

Tel: +1-404-371-0466

 

Photos on home page by Tayvessa Wilson, Conor Ashleigh, and Zunaid Murshed Paiker

Support us

Donate

Follow us

  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep

Sign up to our newsletter

<

Footer

  • Contact
© 2019 - 2021 Coalition for Global Hepatitis Elimination
Website by Manta Ray Media
q